23 December,2022 12:46 PM IST | New Delhi | mid-day online correspondent
Representative image
The Union Health Ministry has given approval to Bharat Biotech's intranasal Covid vaccine for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said. The needle-free vaccine will be available at private vaccination centres.
The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries. "The needle-free vaccine will be introduced on the Co-WIN platform on Friday evening," they said.
Also read: Maharashtra: Time to mask up in crowded places, says Health minister
The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
ALSO READ
Mid-Day Top News: Maharashtra assembly polls likely only after Diwali and more
Congress: Centre insensitive to statehood restoration demand, will be poll issue
Haryana Assembly elections: Ramdas Athawale's RPI(A) seeks 2 seats from BJP
NC to prioritise lifting of AFSPA if voted to power in J-K, says Omar Abdullah
BJP may ally with regional parties, independents: Omar Abdullah
(with inputs from PTI)